Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

Mesenchymal stromal cell potency to treat acute kidney injury increased by ultrasound-activated interferon-γ/interleukin-10 axis.

Burks SR, Nagle ME, Bresler MN, Kim SJ, Star RA, Frank JA.

J Cell Mol Med. 2018 Dec;22(12):6015-6025. doi: 10.1111/jcmm.13874. Epub 2018 Sep 14.

2.

Rebuilding the Pipeline of Investigators in Nephrology Research in the United States.

Norton JM, Ketchum CJ, Rankin TL, Star RA.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1285-1287. doi: 10.2215/CJN.03360318. Epub 2018 Jul 17. No abstract available.

PMID:
30018051
3.

Overcoming Translational Barriers in Acute Kidney Injury: A Report from an NIDDK Workshop.

Zuk A, Palevsky PM, Fried L, Harrell FE Jr, Khan S, McKay DB, Devey L, Chawla L, de Caestecker M, Kaufman JS, Thompson BT, Agarwal A, Greene T, Okusa MD, Bonventre JV, Dember LM, Liu KD, Humphreys BD, Gossett D, Xie Y, Norton JM, Kimmel PL, Star RA.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1113-1123. doi: 10.2215/CJN.06820617. Epub 2018 Mar 9.

PMID:
29523680
4.

Research Needs to Understand Self-Management of Lower Urinary Tract Symptoms: Summary of NIDDK Workshop.

Norton JM, Bavendam TG, Elwood W, Jacobsen SJ, Kaplan SA, Kusek JW, Xie Y, Star RA, Kirkali Z.

J Urol. 2018 Jun;199(6):1408-1410. doi: 10.1016/j.juro.2017.11.079. Epub 2017 Dec 2. No abstract available.

PMID:
29199000
5.

The role of adenosine 1a receptor signaling on GFR early after the induction of sepsis.

Street JM, Koritzinsky EH, Bellomo TR, Hu X, Yuen PST, Star RA.

Am J Physiol Renal Physiol. 2018 May 1;314(5):F788-F797. doi: 10.1152/ajprenal.00051.2017. Epub 2017 Nov 8.

PMID:
29117994
6.

Mitochondrial DNA-enriched microparticles promote acute-on-chronic alcoholic neutrophilia and hepatotoxicity.

Cai Y, Xu MJ, Koritzinsky EH, Zhou Z, Wang W, Cao H, Yuen PS, Ross RA, Star RA, Liangpunsakul S, Gao B.

JCI Insight. 2017 Jul 20;2(14). pii: 92634. doi: 10.1172/jci.insight.92634. [Epub ahead of print]

7.

Complementary Initiatives from the NIDDK to Advance Kidney Health.

Norton JM, Ketchum CJ, Narva AS, Star RA, Rodgers GP.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1544-1547. doi: 10.2215/CJN.02120217. Epub 2017 Jul 17. No abstract available.

8.

Nonbiologic factors that impact management in women with urinary incontinence: review of the literature and findings from a National Institute of Diabetes and Digestive and Kidney Diseases workshop.

Norton JM, Dodson JL, Newman DK, Rogers RG, Fairman AD, Coons HL, Star RA, Bavendam TG.

Int Urogynecol J. 2017 Sep;28(9):1295-1307. doi: 10.1007/s00192-017-3400-x. Epub 2017 Jul 3. Review.

PMID:
28674734
9.

Developing a neonatal acute kidney injury research definition: a report from the NIDDK neonatal AKI workshop.

Zappitelli M, Ambalavanan N, Askenazi DJ, Moxey-Mims MM, Kimmel PL, Star RA, Abitbol CL, Brophy PD, Hidalgo G, Hanna M, Morgan CM, Raju TNK, Ray P, Reyes-Bou Z, Roushdi A, Goldstein SL.

Pediatr Res. 2017 Oct;82(4):569-573. doi: 10.1038/pr.2017.136. Epub 2017 Jul 11. No abstract available.

PMID:
28604760
10.

Human SR-BII mediates SAA uptake and contributes to SAA pro-inflammatory signaling in vitro and in vivo.

Baranova IN, Souza ACP, Bocharov AV, Vishnyakova TG, Hu X, Vaisman BL, Amar MJ, Chen Z, Remaley AT, Patterson AP, Yuen PST, Star RA, Eggerman TL.

PLoS One. 2017 Apr 19;12(4):e0175824. doi: 10.1371/journal.pone.0175824. eCollection 2017.

11.

Future Directions of Research and Care for Urinary Incontinence: Findings from the National Institute of Diabetes and Digestive and Kidney Diseases Summit on Urinary Incontinence Clinical Research in Women.

Chai TC, Asfaw TS, Baker JE, Clarkson B, Coleman P, Hoffstetter S, Konkel K, Lavender M, Nair S, Norton J, Subak L, Visco A, Star RA, Bavendam T.

J Urol. 2017 Jul;198(1):22-29. doi: 10.1016/j.juro.2016.10.133. Epub 2017 Mar 9. Review.

PMID:
28286067
12.

Research Needs for Effective Transition in Lifelong Care of Congenital Genitourinary Conditions: A Workshop Sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases.

Hsieh MH, Wood HM, Dicianno BE, Dosa NP, Gomez-Lobo V, Mattoo TK, Misseri R, Norton JM, Sawin KJ, Scal P, Wright JE 3rd, Star RA, Bavendam T.

Urology. 2017 May;103:261-271. doi: 10.1016/j.urology.2016.12.052. Epub 2017 Feb 2. Review.

13.

Urine Exosomes: An Emerging Trove of Biomarkers.

Street JM, Koritzinsky EH, Glispie DM, Star RA, Yuen PS.

Adv Clin Chem. 2017;78:103-122. doi: 10.1016/bs.acc.2016.07.003. Epub 2016 Aug 18. Review.

PMID:
28057185
14.

Advancing a Comprehensive Approach to the Study of Lower Urinary Tract Symptoms.

Bavendam TG, Norton JM, Kirkali Z, Mullins C, Kusek JW, Star RA, Rodgers GP.

J Urol. 2016 Nov;196(5):1342-1349. doi: 10.1016/j.juro.2016.05.117. Epub 2016 Jun 21. Review.

15.

Research to Improve Urological Health for Women and Girls: Focus on Prevention.

Bavendam TG, Star RA, Rodgers GP.

J Womens Health (Larchmt). 2016 Nov;25(11):1081-1082. Epub 2016 May 16. No abstract available.

PMID:
27182742
16.

Social Determinants of Racial Disparities in CKD.

Norton JM, Moxey-Mims MM, Eggers PW, Narva AS, Star RA, Kimmel PL, Rodgers GP.

J Am Soc Nephrol. 2016 Sep;27(9):2576-95. doi: 10.1681/ASN.2016010027. Epub 2016 May 13. Review.

17.

Quantification of Exosomes.

Koritzinsky EH, Street JM, Star RA, Yuen PS.

J Cell Physiol. 2017 Jul;232(7):1587-1590. doi: 10.1002/jcp.25387. Epub 2017 Mar 1. Review.

18.

Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation.

Souza AC, Bocharov AV, Baranova IN, Vishnyakova TG, Huang YG, Wilkins KJ, Hu X, Street JM, Alvarez-Prats A, Mullick AE, Patterson AP, Remaley AT, Eggerman TL, Yuen PS, Star RA.

Kidney Int. 2016 Apr;89(4):809-22. doi: 10.1016/j.kint.2015.12.043.

19.

Urinary Stone Disease: Advancing Knowledge, Patient Care, and Population Health.

Scales CD Jr, Tasian GE, Schwaderer AL, Goldfarb DS, Star RA, Kirkali Z.

Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1305-12. doi: 10.2215/CJN.13251215. Epub 2016 Mar 10. Review.

20.

Human SR-BI and SR-BII Potentiate Lipopolysaccharide-Induced Inflammation and Acute Liver and Kidney Injury in Mice.

Baranova IN, Souza AC, Bocharov AV, Vishnyakova TG, Hu X, Vaisman BL, Amar MJ, Chen Z, Kost Y, Remaley AT, Patterson AP, Yuen PS, Star RA, Eggerman TL.

J Immunol. 2016 Apr 1;196(7):3135-47. doi: 10.4049/jimmunol.1501709. Epub 2016 Mar 2.

21.

Strategies to improve the understanding of long-term renal consequences after neonatal acute kidney injury.

Askenazi DJ, Morgan C, Goldstein SL, Selewski DT, Moxey-Mims MM, Kimmel PL, Star RA, Higgins R, Laughon M.

Pediatr Res. 2016 Mar;79(3):502-8. doi: 10.1038/pr.2015.241. Epub 2015 Nov 23. No abstract available.

PMID:
26595535
22.

The Authors Reply.

Souza AC, Yuen PS, Star RA.

Kidney Int. 2015 Oct;88(4):915-6. doi: 10.1038/ki.2015.209. No abstract available.

23.

TLR4 mutant mice are protected from renal fibrosis and chronic kidney disease progression.

Souza AC, Tsuji T, Baranova IN, Bocharov AV, Wilkins KJ, Street JM, Alvarez-Prats A, Hu X, Eggerman T, Yuen PS, Star RA.

Physiol Rep. 2015 Sep;3(9). pii: e12558. doi: 10.14814/phy2.12558.

24.

Urinary Stone Disease: Progress, Status, and Needs.

Kirkali Z, Rasooly R, Star RA, Rodgers GP.

Urology. 2015 Oct;86(4):651-3. doi: 10.1016/j.urology.2015.07.006. Epub 2015 Jul 17. Review.

25.

Microparticles: markers and mediators of sepsis-induced microvascular dysfunction, immunosuppression, and AKI.

Souza AC, Yuen PS, Star RA.

Kidney Int. 2015 Jun;87(6):1100-8. doi: 10.1038/ki.2015.26. Epub 2015 Feb 18. Review.

26.

Pulsed focused ultrasound pretreatment improves mesenchymal stromal cell efficacy in preventing and rescuing established acute kidney injury in mice.

Burks SR, Nguyen BA, Tebebi PA, Kim SJ, Bresler MN, Ziadloo A, Street JM, Yuen PS, Star RA, Frank JA.

Stem Cells. 2015 Apr;33(4):1241-53. doi: 10.1002/stem.1965.

27.

The kidney research national dialogue: gearing up to move forward.

Bonventre JV, Boulware LE, Dember LM, Freedman BI, Furth SL, Holzman LB, Ketchum CJ, Little MH, Mehrotra R, Moe SM, Sands JM, Sedor JR, Somlo S, Star RA, Rys-Sikora KE; Kidney Research National Dialogue (KRND).

Clin J Am Soc Nephrol. 2014 Oct 7;9(10):1806-11. doi: 10.2215/CJN.07310714. Epub 2014 Sep 15. Review.

28.

Comparison of serum creatinine and serum cystatin C as biomarkers to detect sepsis-induced acute kidney injury and to predict mortality in CD-1 mice.

Leelahavanichkul A, Souza AC, Street JM, Hsu V, Tsuji T, Doi K, Li L, Hu X, Zhou H, Kumar P, Schnermann J, Star RA, Yuen PS.

Am J Physiol Renal Physiol. 2014 Oct 15;307(8):F939-48. doi: 10.1152/ajprenal.00025.2013. Epub 2014 Aug 20.

29.

Automated quantification of renal fibrosis with Sirius Red and polarization contrast microscopy.

Street JM, Souza AC, Alvarez-Prats A, Horino T, Hu X, Yuen PS, Star RA.

Physiol Rep. 2014 Jul 22;2(7). pii: e12088. doi: 10.14814/phy2.12088. Print 2014 Jul 1.

30.

Acute kidney injury and chronic kidney disease as interconnected syndromes.

Chawla LS, Eggers PW, Star RA, Kimmel PL.

N Engl J Med. 2014 Jul 3;371(1):58-66. doi: 10.1056/NEJMra1214243. Review. No abstract available.

PMID:
24988558
31.

The last mile: translational research to improve CKD outcomes.

Tuot DS, Diamantidis CJ, Corbett CF, Boulware LE, Fox CH, Harwood DH, Star RA, Rys-Sikora KE, Narva A.

Clin J Am Soc Nephrol. 2014 Oct 7;9(10):1802-5. doi: 10.2215/CJN.04310514. Epub 2014 Jun 26.

32.

Filling the holes in cystic kidney disease research.

Guay-Woodford LM, Henske E, Igarashi P, Perrone RD, Reed-Gitomer B, Somlo S, Torres VE, Ketchum CJ, Star RA, Flessner MF, Rasooly RS.

Clin J Am Soc Nephrol. 2014 Oct 7;9(10):1799-801. doi: 10.2215/CJN.03410414. Epub 2014 Jun 5. Review.

33.

Bioactive exosomes: possibilities for diagnosis and management of bladder cancer.

Street JM, Yuen PS, Star RA.

J Urol. 2014 Aug;192(2):297-8. doi: 10.1016/j.juro.2014.05.050. Epub 2014 May 15. No abstract available.

PMID:
24837807
34.

Glomerular disease: looking beyond pathology.

Wiggins RC, Alpers CE, Holzman LB, He JC, Salant DJ, Chugh SS, Natarajan R, Trachtman H, Brasile L, Star RA, Rys-Sikora KE, Moxey-Mims MM, Flessner MF; Kidney Research National Dialogue.

Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1138-40. doi: 10.2215/CJN.01450214. Epub 2014 Apr 3.

35.

Improving CKD therapies and care: a National Dialogue.

Kaskel F, Batlle D, Beddhu S, Daugirdas J, Feldman H, Ferris M, Fine L, Freedman BI, Kimmel PL, Flessner MF, Star RA; Kidney Research National Dialogue (KRND).

Clin J Am Soc Nephrol. 2014 Apr;9(4):815-7. doi: 10.2215/CJN.12631213. Epub 2014 Feb 7.

36.

AKI: a path forward.

Bonventre JV, Basile D, Liu KD, McKay D, Molitoris BA, Nath KA, Nickolas TL, Okusa MD, Palevsky PM, Schnellmann R, Rys-Sikora K, Kimmel PL, Star RA; Kidney Research National Dialogue (KRND).

Clin J Am Soc Nephrol. 2013 Sep;8(9):1606-8. doi: 10.2215/CJN.06040613. Epub 2013 Jul 18.

37.

Kidney research national dialogue overview and commentary.

Rys-Sikora KE, Ketchum CJ, Star RA; Kidney Research National Dialogue (KRND) Editorial Board.

Clin J Am Soc Nephrol. 2013 Sep;8(9):1599-602. doi: 10.2215/CJN.03590413. Epub 2013 Jun 20. Review.

38.

Urinary exosomal Wilms' tumor-1 as a potential biomarker for podocyte injury.

Zhou H, Kajiyama H, Tsuji T, Hu X, Leelahavanichkul A, Vento S, Frank R, Kopp JB, Trachtman H, Star RA, Yuen PS.

Am J Physiol Renal Physiol. 2013 Aug 15;305(4):F553-9. doi: 10.1152/ajprenal.00056.2013. Epub 2013 Jun 12.

39.

Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trials.

Okusa MD, Molitoris BA, Palevsky PM, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Faubel S, Kellum JA, Wald R, Chertow GM, Levin A, Waikar SS, Murray PT, Parikh CR, Shaw AD, Go AS, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene TH, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA.

Clin J Am Soc Nephrol. 2012 May;7(5):851-5. doi: 10.2215/CJN.12811211. Epub 2012 Mar 22.

40.

Designing clinical trials in acute kidney injury.

Molitoris BA, Okusa MD, Palevsky PM, Kimmel PL, Star RA.

Clin J Am Soc Nephrol. 2012 May;7(5):842-3. doi: 10.2215/CJN.12801211. Epub 2012 Mar 22. No abstract available.

41.

Design of clinical trials in AKI: a report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings.

Molitoris BA, Okusa MD, Palevsky PM, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene TH, Faubel SG, Kellum JA, Wald R, Chertow GM, Levin A, Waikar SS, Murray PT, Parikh CR, Shaw AD, Go AS, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA.

Clin J Am Soc Nephrol. 2012 May;7(5):856-60. doi: 10.2215/CJN.12821211. Epub 2012 Mar 22.

42.

Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology.

Palevsky PM, Molitoris BA, Okusa MD, Levin A, Waikar SS, Wald R, Chertow GM, Murray PT, Parikh CR, Shaw AD, Go AS, Faubel SG, Kellum JA, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene T, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA.

Clin J Am Soc Nephrol. 2012 May;7(5):844-50. doi: 10.2215/CJN.12791211. Epub 2012 Mar 22.

43.

Class B scavenger receptor types I and II and CD36 targeting improves sepsis survival and acute outcomes in mice.

Leelahavanichkul A, Bocharov AV, Kurlander R, Baranova IN, Vishnyakova TG, Souza AC, Hu X, Doi K, Vaisman B, Amar M, Sviridov D, Chen Z, Remaley AT, Csako G, Patterson AP, Yuen PS, Star RA, Eggerman TL.

J Immunol. 2012 Mar 15;188(6):2749-58. doi: 10.4049/jimmunol.1003445. Epub 2012 Feb 10.

44.

Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release.

Zafrani L, Gerotziafas G, Byrnes C, Hu X, Perez J, Lévi C, Placier S, Letavernier E, Leelahavanichkul A, Haymann JP, Elalamy I, Miller JL, Star RA, Yuen PS, Baud L.

Am J Respir Crit Care Med. 2012 Apr 1;185(7):744-55. doi: 10.1164/rccm.201109-1686OC. Epub 2012 Jan 20.

45.

Class B scavenger receptor types I and II and CD36 mediate bacterial recognition and proinflammatory signaling induced by Escherichia coli, lipopolysaccharide, and cytosolic chaperonin 60.

Baranova IN, Vishnyakova TG, Bocharov AV, Leelahavanichkul A, Kurlander R, Chen Z, Souza AC, Yuen PS, Star RA, Csako G, Patterson AP, Eggerman TL.

J Immunol. 2012 Feb 1;188(3):1371-80. doi: 10.4049/jimmunol.1100350. Epub 2011 Dec 28.

46.

Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing High Mobility Group Box Protein-1.

Leelahavanichkul A, Huang Y, Hu X, Zhou H, Tsuji T, Chen R, Kopp JB, Schnermann J, Yuen PS, Star RA.

Kidney Int. 2011 Dec;80(11):1198-211. doi: 10.1038/ki.2011.261. Epub 2011 Aug 10.

47.

The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial.

Rocco MV, Lockridge RS Jr, Beck GJ, Eggers PW, Gassman JJ, Greene T, Larive B, Chan CT, Chertow GM, Copland M, Hoy CD, Lindsay RM, Levin NW, Ornt DB, Pierratos A, Pipkin MF, Rajagopalan S, Stokes JB, Unruh ML, Star RA, Kliger AS; Frequent Hemodialysis Network (FHN) Trial Group, Kliger A, Eggers P, Briggs J, Hostetter T, Narva A, Star R, Augustine B, Mohr P, Beck G, Fu Z, Gassman J, Greene T, Daugirdas J, Hunsicker L, Larive B, Li M, Mackrell J, Wiggins K, Sherer S, Weiss B, Rajagopalan S, Sanz J, Dellagrottaglie S, Kariisa M, Tran T, West J, Unruh M, Keene R, Schlarb J, Chan C, McGrath-Chong M, Frome R, Higgins H, Ke S, Mandaci O, Owens C, Snell C, Eknoyan G, Appel L, Cheung A, Derse A, Kramer C, Geller N, Grimm R, Henderson L, Prichard S, Roecker E, Rocco M, Miller B, Riley J, Schuessler R, Lockridge R, Pipkin M, Peterson C, Hoy C, Fensterer A, Steigerwald D, Stokes J, Somers D, Hilkin A, Lilli K, Wallace W, Franzwa B, Waterman E, Chan C, McGrath-Chong M, Copland M, Levin A, Sioson L, Cabezon E, Kwan S, Roger D, Lindsay R, Suri R, Champagne J, Bullas R, Garg A, Mazzorato A, Spanner E, Rocco M, Burkart J, Moossavi S, Mauck V, Kaufman T, Pierratos A, Chan W, Regozo K, Kwok S.

Kidney Int. 2011 Nov;80(10):1080-91. doi: 10.1038/ki.2011.213. Epub 2011 Jul 20.

48.

In-center hemodialysis six times per week versus three times per week.

FHN Trial Group, Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS.

N Engl J Med. 2010 Dec 9;363(24):2287-300. doi: 10.1056/NEJMoa1001593. Epub 2010 Nov 20. Erratum in: N Engl J Med. 2011 Jan 6;364(1):93.

49.

Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model.

Leelahavanichkul A, Yan Q, Hu X, Eisner C, Huang Y, Chen R, Mizel D, Zhou H, Wright EC, Kopp JB, Schnermann J, Yuen PS, Star RA.

Kidney Int. 2010 Dec;78(11):1136-53. doi: 10.1038/ki.2010.287. Epub 2010 Aug 25.

50.

Isolation and purification of exosomes in urine.

Gonzales PA, Zhou H, Pisitkun T, Wang NS, Star RA, Knepper MA, Yuen PS.

Methods Mol Biol. 2010;641:89-99. doi: 10.1007/978-1-60761-711-2_6.

PMID:
20407943

Supplemental Content

Support Center